Item Type | Name |
Concept
|
Acute Disease
|
Concept
|
Administration, Inhalation
|
Concept
|
Administration, Intranasal
|
Concept
|
Amitriptyline
|
Concept
|
Analgesics
|
Concept
|
Analgesics, Opioid
|
Concept
|
Anesthetics, Local
|
Concept
|
Angina, Unstable
|
Concept
|
Angiotensin-Converting Enzyme Inhibitors
|
Concept
|
Animals
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
Concept
|
Antibodies, Monoclonal
|
Concept
|
Anticonvulsants
|
Concept
|
Antiemetics
|
Concept
|
Arrhythmias, Cardiac
|
Concept
|
Auditory Cortex
|
Concept
|
Bayes Theorem
|
Concept
|
Benzamides
|
Concept
|
Betamethasone
|
Concept
|
Blood Glucose
|
Concept
|
California
|
Concept
|
Capsaicin
|
Concept
|
Central Nervous System Agents
|
Concept
|
Intracranial Aneurysm
|
Concept
|
Cerebrospinal Fluid Rhinorrhea
|
Concept
|
Cholesterol
|
Concept
|
Chronic Disease
|
Concept
|
Clinical Trials as Topic
|
Concept
|
Cluster Headache
|
Concept
|
Congresses as Topic
|
Concept
|
Connecticut
|
Concept
|
Coronary Vasospasm
|
Concept
|
Cross-Sectional Studies
|
Concept
|
Data Collection
|
Concept
|
Dexamethasone
|
Concept
|
Dihydroergotamine
|
Concept
|
Disease Susceptibility
|
Concept
|
Dizziness
|
Concept
|
Dose-Response Relationship, Drug
|
Concept
|
Double-Blind Method
|
Concept
|
Electric Stimulation Therapy
|
Concept
|
Embolization, Therapeutic
|
Concept
|
Emergency Service, Hospital
|
Concept
|
Ergotamine
|
Concept
|
Ergotamines
|
Concept
|
Estrogens
|
Concept
|
Europe
|
Concept
|
Follow-Up Studies
|
Concept
|
Ganglia, Parasympathetic
|
Concept
|
Glucocorticoids
|
Concept
|
Headache
|
Concept
|
Medicare
|
Concept
|
Health Status
|
Concept
|
Health Surveys
|
Concept
|
Hospitalization
|
Concept
|
Humans
|
Concept
|
Hyperalgesia
|
Concept
|
Immunologic Factors
|
Concept
|
Injections
|
Concept
|
Injections, Intradermal
|
Concept
|
Injections, Spinal
|
Concept
|
Injections, Subcutaneous
|
Concept
|
Insulin
|
Concept
|
Iron
|
Concept
|
Italy
|
Concept
|
Kidney Failure, Chronic
|
Concept
|
Lidocaine
|
Concept
|
Longitudinal Studies
|
Concept
|
Magnesium
|
Concept
|
Magnesium Deficiency
|
Concept
|
Magnetic Resonance Imaging
|
Concept
|
Markov Chains
|
Concept
|
Mass Screening
|
Concept
|
Medicaid
|
Concept
|
Medical Records
|
Concept
|
Medicine, Ayurvedic
|
Concept
|
Memantine
|
Concept
|
Memory Disorders
|
Concept
|
Menstruation Disturbances
|
Concept
|
Migraine Disorders
|
Concept
|
Military Personnel
|
Concept
|
Models, Psychological
|
Concept
|
Models, Theoretical
|
Concept
|
Monoamine Oxidase Inhibitors
|
Concept
|
Myocardial Infarction
|
Concept
|
Myocardial Revascularization
|
Concept
|
Naphthalenesulfonates
|
Concept
|
Naproxen
|
Concept
|
Nerve Block
|
Concept
|
Neurologic Examination
|
Concept
|
Neuromuscular Agents
|
Concept
|
New York City
|
Concept
|
Terminology as Topic
|
Concept
|
Obstetrics and Gynecology Department, Hospital
|
Concept
|
Oxygen
|
Concept
|
Pain Measurement
|
Concept
|
Pain, Intractable
|
Concept
|
Patents as Topic
|
Concept
|
Patient Acceptance of Health Care
|
Concept
|
Patient Compliance
|
Concept
|
Patient Education as Topic
|
Concept
|
Practice Patterns, Physicians'
|
Concept
|
Physicians
|
Concept
|
Pilot Projects
|
Concept
|
Predictive Value of Tests
|
Concept
|
Premenstrual Syndrome
|
Concept
|
Drug Prescriptions
|
Concept
|
Primary Health Care
|
Concept
|
Prospective Studies
|
Concept
|
Pyrroles
|
Concept
|
Quality of Life
|
Concept
|
Surveys and Questionnaires
|
Concept
|
Receptors, Serotonin
|
Concept
|
Hyperacusis
|
Concept
|
Recurrence
|
Concept
|
Reflex
|
Concept
|
Registries
|
Concept
|
Retrospective Studies
|
Concept
|
Risk
|
Concept
|
Risk Factors
|
Concept
|
Sampling Studies
|
Concept
|
San Francisco
|
Concept
|
Seasons
|
Concept
|
Serotonin
|
Concept
|
Serotonin Antagonists
|
Concept
|
Severity of Illness Index
|
Concept
|
Sleep Wake Disorders
|
Concept
|
Societies, Medical
|
Concept
|
Sweden
|
Concept
|
Switzerland
|
Concept
|
Syndrome
|
Concept
|
Giant Cell Arteritis
|
Concept
|
Tinnitus
|
Concept
|
Tobacco
|
Concept
|
United States
|
Concept
|
United States Food and Drug Administration
|
Concept
|
Vasoconstrictor Agents
|
Concept
|
Vertigo
|
Concept
|
Weather
|
Concept
|
World Health Organization
|
Concept
|
Reproducibility of Results
|
Concept
|
Octreotide
|
Concept
|
Cohort Studies
|
Concept
|
Precipitating Factors
|
Concept
|
Prevalence
|
Concept
|
Cluster Analysis
|
Concept
|
Survival Analysis
|
Concept
|
Epidemiologic Studies
|
Concept
|
Case-Control Studies
|
Concept
|
Randomized Controlled Trials as Topic
|
Concept
|
Torsades de Pointes
|
Concept
|
Treatment Outcome
|
Concept
|
Models, Econometric
|
Concept
|
Outcome Assessment (Health Care)
|
Concept
|
Treatment Failure
|
Concept
|
Telemedicine
|
Concept
|
Cost of Illness
|
Concept
|
Photosensitizing Agents
|
Concept
|
Serotonin Receptor Agonists
|
Concept
|
Serotonin Uptake Inhibitors
|
Concept
|
Magnesium Compounds
|
Concept
|
Receptors, Calcitonin Gene-Related Peptide
|
Concept
|
Sumatriptan
|
Concept
|
Neurotransmitter Agents
|
Concept
|
Sickness Impact Profile
|
Concept
|
Patient Selection
|
Concept
|
Cross-Over Studies
|
Concept
|
Excitatory Amino Acid Antagonists
|
Concept
|
Pain Clinics
|
Concept
|
Analgesics, Non-Narcotic
|
Concept
|
Controlled Clinical Trials as Topic
|
Concept
|
Quality-Adjusted Life Years
|
Concept
|
Botulinum Toxins, Type A
|
Concept
|
Disease Management
|
Concept
|
Health Care Surveys
|
Concept
|
Dietary Supplements
|
Concept
|
Neurosurgical Procedures
|
Concept
|
Databases as Topic
|
Concept
|
Migraine with Aura
|
Concept
|
Migraine without Aura
|
Concept
|
Headache Disorders
|
Concept
|
Photophobia
|
Concept
|
Ethics, Clinical
|
Concept
|
Receptor, Serotonin, 5-HT1B
|
Concept
|
Receptor, Serotonin, 5-HT1D
|
Concept
|
Receptor, Serotonin, 5-HT2A
|
Concept
|
History, 15th Century
|
Concept
|
History, 17th Century
|
Concept
|
History, 18th Century
|
Concept
|
History, 19th Century
|
Concept
|
History, 20th Century
|
Concept
|
Headache Disorders, Primary
|
Concept
|
Headache Disorders, Secondary
|
Concept
|
Post-Traumatic Headache
|
Concept
|
Trigeminal Autonomic Cephalalgias
|
Concept
|
Cytochrome P-450 CYP3A
|
Concept
|
Adiponectin
|
Concept
|
Foramen Ovale, Patent
|
Concept
|
Iraq War, 2003-2011
|
Concept
|
Medication Adherence
|
Concept
|
Afghan Campaign 2001-
|
Concept
|
Patient Preference
|
Concept
|
Endovascular Procedures
|
Concept
|
Peripheral Arterial Disease
|
Concept
|
Serotonin 5-HT1 Receptor Agonists
|
Concept
|
Nasal Sprays
|
Concept
|
Chronic Pain
|
Concept
|
Functional Neuroimaging
|
Concept
|
Antibodies, Monoclonal, Humanized
|
Concept
|
Time-to-Treatment
|
Academic Article
|
MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.
|
Academic Article
|
MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments.
|
Academic Article
|
Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia.
|
Academic Article
|
AVP-825 Breath-Powered Intranasal Delivery System Containing 22?mg Sumatriptan Powder vs 100?mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks.
|
Academic Article
|
Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study.
|
Academic Article
|
Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan.
|
Concept
|
Prescription Drug Overuse
|
Concept
|
Smartphone
|
Concept
|
Network Meta-Analysis
|
Concept
|
Acetylcholine Release Inhibitors
|
Concept
|
Cerebrospinal Fluid Leak
|
Concept
|
Patient Reported Outcome Measures
|
Concept
|
Observational Studies as Topic
|
Academic Article
|
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
|
Academic Article
|
Role of melatonin in the pathophysiology of migraine: implications for treatment.
|
Academic Article
|
Neurostimulation for primary headache disorders: Part 2, review of central neurostimulators for primary headache, overall therapeutic efficacy, safety, cost, patient selection, and future research in headache neuromodulation.
|
Academic Article
|
Cluster headache: potential options for medically refractory patients (when all else fails).
|
Academic Article
|
Medication-Overuse Headache: Protocols and Outcomes in 149 Consecutive Patients in a Tertiary Brazilian Headache Center.
|
Academic Article
|
Ethical considerations in cluster headache research.
|
Academic Article
|
Editorial: Understanding Menstrual Migraine.
|
Academic Article
|
Chronic daily headache: identification of factors associated with induction and transformation.
|
Academic Article
|
Acute treatment of basilar-type migraine with greater occipital nerve blockade.
|
Academic Article
|
Editorial: traumatic brain injury (TBI), pain, and headache.
|
Academic Article
|
A pivotal moment in 50 years of headache history: the first American Migraine Study.
|
Academic Article
|
Revisiting the role of ergots in the treatment of migraine and headache.
|
Academic Article
|
Editorial: Nutraceuticals and Occipital Nerve Blocks.
|
Academic Article
|
Menstrual Migraine and Treatment Options-A Response.
|
Academic Article
|
New paradigms in the recognition and acute treatment of migraine.
|
Academic Article
|
The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper.
|
Academic Article
|
Antiepilepsy Drugs in Migraine Prevention: Editorial.
|
Academic Article
|
Neurostimulation for primary headache disorders, part 1: pathophysiology and anatomy, history of neuromodulation in headache treatment, and review of peripheral neuromodulation in primary headaches.
|
Academic Article
|
Opioids should not be used in migraine.
|
Academic Article
|
Editorial: The Importance of the Idiopathic Intracranial Hypertension Treatment Trial.
|
Academic Article
|
Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018.
|
Academic Article
|
Structural and functional neuroimaging in migraine: insights from 3 decades of research.
|
Academic Article
|
Medication overuse headache.
|
Academic Article
|
Editorial--Indomethacin.
|
Academic Article
|
Peripheral nerve blocks and trigger point injections in headache management - a systematic review and suggestions for future research.
|
Academic Article
|
Conclusions on opioids.
|
Academic Article
|
New migraine preventive options: an update with pathophysiological considerations.
|
Academic Article
|
Editorial: complementary and Alternative Medicine (CAM), Ayurvedic medicine, and research into behavioral and mind/body interventions in headache.
|
Academic Article
|
Alcohol, Tobacco, Triggers, and Headache Disorders.
|
Academic Article
|
Economics of Inhaled Oxygen Use as an Acute Therapy for Cluster Headache in the United States of America.
|
Academic Article
|
Long-Term Outcomes and Clinical Characteristics of Hypnic Headache Syndrome: 40 Patients Series From a Tertiary Referral Center.
|
Academic Article
|
Retrospective outcome analyses for headaches in a pain rehabilitation interdisciplinary program.
|
Academic Article
|
Safety profile of the triptans.
|
Academic Article
|
Reliability, validity, and clinical utility of the Migraine-ACT questionnaire.
|
Academic Article
|
History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
|
Academic Article
|
The SUN Also Rises.
|
Academic Article
|
The classification of chronic daily headache in adolescents--a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria.
|
Academic Article
|
Iron deposition in pain-regulatory nuclei in episodic migraine and chronic daily headache by MRI.
|
Academic Article
|
Headache following intracranial neuroendovascular procedures.
|
Academic Article
|
Frequency of Migraine Headaches in Patients With Fibromyalgia.
|
Academic Article
|
QT prolongation, Torsade de Pointes, myocardial ischemia from coronary vasospasm, and headache medications. Part 2: review of headache medications, drug-drug interactions, QTc prolongation, and other arrhythmias.
|
Academic Article
|
Chronic migraine and medication overuse headache.
|
Academic Article
|
Serotonin syndrome: SSRIs, SNRIs, triptans, and current clinical practice.
|
Academic Article
|
Treatment persistence and switching in triptan users: a systematic literature review.
|
Academic Article
|
Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker.
|
Academic Article
|
Sphenopalatine Ganglion (SPG): Stimulation Mechanism, Safety, and Efficacy.
|
Academic Article
|
Mechanisms of action of the 5-HT1B/1D receptor agonists.
|
Academic Article
|
Patterns of use of peripheral nerve blocks and trigger point injections among headache practitioners in the USA: Results of the American Headache Society Interventional Procedure Survey (AHS-IPS).
|
Academic Article
|
Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
|
Academic Article
|
Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.
|
Academic Article
|
The serotonin syndrome, triptans, and the potential for drug-drug interactions.
|
Academic Article
|
Adherence to acute migraine medication: what does it mean, why does it matter?
|
Academic Article
|
Burden of migraine in Brazil: estimate of cost of migraine to the public health system and an analytical study of the cost-effectiveness of a stratified model of care.
|
Academic Article
|
Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
|
Academic Article
|
Prescribing Oxygen for Cluster Headache: A Guide for the Provider.
|
Academic Article
|
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
|
Academic Article
|
Advanced interventions for headache.
|
Academic Article
|
Ergotamine and dihydroergotamine: a review.
|
Academic Article
|
Expert opinion: Rescue me: rescue medication for migraine.
|
Academic Article
|
Electrical stimulation of sphenopalatine ganglion for acute treatment of cluster headaches.
|
Academic Article
|
Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine.
|
Academic Article
|
Cyclic vomiting syndrome, inborn errors of metabolism, migraine variants, episodic syndromes that may be associated with migraine, and other unusual pediatric headache syndromes.
|
Academic Article
|
Ictal adiponectin levels in episodic migraineurs: a randomized pilot trial.
|
Academic Article
|
The effect of weather on headache.
|
Academic Article
|
Side-locked and side shifting primary headaches.
|
Academic Article
|
Menstrual Migraine and Treatment Options: Review.
|
Academic Article
|
Debate: analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is a cause of chronic daily headache.
|
Academic Article
|
An overview of migraine pathophysiology.
|
Academic Article
|
Orally inhaled dihydroergotamine: a review.
|
Academic Article
|
Characterization of Dizziness After Lasmiditan Usage: Findings From the SAMURAI and SPARTAN Acute Migraine Treatment Randomized Trials.
|
Academic Article
|
QT prolongation, Torsade de Pointes, myocardial ischemia from coronary vasospasm, and headache medications. Part 1: review of serotonergic cardiac adverse events with a triptan case.
|
Academic Article
|
Intranasal zolmitriptan for the treatment of acute migraine.
|
Academic Article
|
Editorial - Acupuncture and Drug Interactions.
|
Academic Article
|
Patent Foramen Ovale and Migraine: Closing the Debate--A Review.
|
Academic Article
|
Drug-induced serotonin syndrome: a review.
|
Academic Article
|
An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.
|
Academic Article
|
Roosevelt's Headache.
|
Academic Article
|
Dihydroergotamine and its use in migraine with posterior fossa symptoms.
|
Academic Article
|
Clinical implications for breath-powered powder sumatriptan intranasal treatment.
|
Academic Article
|
Idiopathic intracranial hypertension and low CSF pressure headaches.
|
Academic Article
|
Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
|
Academic Article
|
Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial.
|
Academic Article
|
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension.
|
Academic Article
|
Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial.
|
Academic Article
|
Network meta-analysis of therapies for cluster headache: Effects of acute therapies for episodic and chronic cluster.
|
Academic Article
|
Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM).
|
Academic Article
|
The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression.
|